GlassScriptPhysician profile
Brent D Reed
NPI 1013201615
$6,170.98
in general payments reported to CMS, 2019-2025
43 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,596 · 2020: $336 · 2021: $585 · 2022: $1,189 · 2023: $1,276 · 2024: $771 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,464.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $971.89 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $741.17 | 2019-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $396.13 | 2019-2025 | Airsupra, Fasenra |
| Pfizer INC. | $358.69 | 2019-2024 | |
| Lilly USA, LLC | $357.21 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $321.14 | 2019-2024 | Steglatro, Gardasil 9, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $308.56 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $278.59 | 2019-2023 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $258.47 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $255.77 | 2022-2023 | |
| Abbvie INC. | $204.03 | 2019-2023 | |
| Amarin Pharma, INC. | $130.80 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.19 | 2019-2023 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $126.59 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $118.16 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.